Editorial : NAFLD, chronic kidney disease, and pleiotropy—Why is PNPLA3 omnipresent?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Alimentary Pharmacology & Therapeutics - 57(2023), 10, Seite 1180-1182 |
| Beteiligte Personen: |
Pirola, Carlos J. [VerfasserIn] |
|---|
| Anmerkungen: |
Copyright © 2023 John Wiley & Sons Ltd. |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1111/apt.17491 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY015091090 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY015091090 | ||
| 003 | DE-627 | ||
| 005 | 20231111130359.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/apt.17491 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_APT_2023_57_10.zip.xml |
| 035 | |a (DE-627)WLY015091090 | ||
| 035 | |a (WILEY)APT17491 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Pirola, Carlos J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Editorial |b NAFLD, chronic kidney disease, and pleiotropy—Why is PNPLA3 omnipresent? |
| 264 | 1 | |c 2023 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Copyright © 2023 John Wiley & Sons Ltd. | ||
| 700 | 1 | |a Sookoian, Silvia |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alimentary Pharmacology & Therapeutics |g 57(2023), 10, Seite 1180-1182 |w (DE-627)WLY002324040 |x 13652036 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2023 |g number:10 |g pages:1180-1182 |g extent:3 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2023 |e 10 |h 1180-1182 |g 3 | ||